Interval Laparoscopy as Predictor of Response to Chemotherapy in Ovarian Carcinoma
- 1 September 1986
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 68 (3) , 345-347
- https://doi.org/10.1097/00006250-198609000-00010
Abstract
Fifty-one patients with FIGO stage III and IV ovarian adenocarcinoma underwent six-month interval laparoscopy for assessment of chemotherapy response. Thirty-nine of these patients were followed by a second-look procedure at 12 months or to disease progression if it occurred earlier. A positive interval laparoscopy was predictive of disease in 91% of patients, whereas a negative interval laparoscopy showed absence of disease at second look in only 70.5% of patients. A positive laparoscopic biopsy at six months showed presence of disease at second look procedure in 100% (11 of 11) of patients. It is concluded that either an intensive initial chemotherapy or change in therapy such as intraperitoneal chemotherapy after positive interval laparoscopy is indicated in future studies.(Obstet Gynecol 68:345, 1986)This publication has 5 references indexed in Scilit:
- Peritoneoscopy in the management of ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1981
- LAPAROSCOPY FOR 2ND-LOOK EVALUATION IN OVARIAN-CANCER1981
- LAPAROSCOPIC FOLLOW-UP OF PATIENTS WITH OVARIAN CARCINOMABJOG: An International Journal of Obstetrics and Gynaecology, 1980
- 2ND-LOOK LAPAROSCOPY PRIOR TO PROPOSED 2ND-LOOK LAPAROTOMY1980
- The value of pre-therapy peritoneoscopy in localized ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1977